High-Risk Prostate Cancer in the Modern Era: Does a Single Standard of Care Exist?
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation
Reference25 articles.
1. Redefining high-risk prostate cancer based on distant metastases and mortality after high-dose radiotherapy with androgen deprivation therapy;Tendulkar;Int J Radiat Oncol Biol Phys,2012
2. Improvement in prostate cancer survival over time: A 20-year analysis;Kim;Cancer,2012
3. Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer;Kuban;Int J Radiat Oncol Biol Phys,2008
4. Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: Long-term results from Proton Radiation Oncology Group/American College of Radiology 95-09;Zietman;J Clin Oncol,2010
5. An update of the Phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen supression: Updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions;Lawton;Int J Radiat Oncol Biol Phys,2007
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Unfavorable Intermediate- and High-Risk Prostate Cancer Treated With Predominantly Brachytherapy Alone With Long-Term Follow-Up;Applied Radiation Oncology;2023-12-01
2. 125I low‑dose‑rate prostate brachytherapy and radical prostatectomy in patients with prostate cancer;Oncology Letters;2019-04-22
3. A Comparison Between Low-Dose-Rate Brachytherapy With or Without Androgen Deprivation, External Beam Radiation Therapy With or Without Androgen Deprivation, and Radical Prostatectomy With or Without Adjuvant or Salvage Radiation Therapy for High-Risk Prostate Cancer;International Journal of Radiation Oncology*Biology*Physics;2017-04
4. Long-term outcomes of intensity-modulated radiation therapy combined with neoadjuvant androgen deprivation therapy under an early salvage policy for patients with T3-T4N0M0 prostate cancer;International Journal of Clinical Oncology;2015-07-04
5. In Reply to Jones and Menon;International Journal of Radiation Oncology*Biology*Physics;2014-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3